Lockheed Martin's NetSense, demonstrated in Miami in July, combines Verizon's 5G spectrum with AI and RF technologies from Nvidia, ODC and Keysight to detect, track and monitor drones in real time.

SpaceX reiterated during its Q2 2026 earnings call that it plans to build its own terrestrial network. Rather than going the capital-intensive traditional route, the company wants to leverage existing ...

Tower firm Array Digital Infrastructure reported an increase of site rental revenues of 95 percent for the second quarter. The company, formerly UScellular, posted total operating revenue of $54.07 ...

Elon Musk--the world’s first trillionaire--has a dizzying array of businesses. For instance, Tesla is the most valuable car ...

T-Mobile US Inc. CEO Srini Gopalan dismissed the threat from Elon Musk’s planned Starlink Mobile service as "exaggerated," ...

SpaceX's first earnings call put the wireless industry on notice. SpaceX CEO Elon Musk and COO Gwynne Shotwell said Starlink was coming for Verizon, AT&T, and T-Mobile. They cited a $600 billion U.S.

University of Bristol–led researchers have identified a naturally occurring gut molecule that could strengthen chickens' immune response against a wide range of bacterial infections. This development, ...

Using real-time two-photon microscopy in living mice, researchers discovered a specialized group of "regenerative" astrocytes that step in to repair damaged brain areas.

The adult brain may be far better at repairing itself than scientists once believed. In mice, researchers discovered a special group of support cells called astrocytes that respond to damaged brain ...

The US is testing a new way to spot drones without building a separate detection network. A new system uses existing 5G infrastructure to detect, track, and monitor unmanned aircraft. Lockheed Martin ...

Introduces Orchestrator AI, the first truly agentic operations solution for converged wireless. Combines private 5G and Wi-Fi under one subscription, with Celona Wi-Fi 7 access points included at no ...

A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine approaches to treat organ rejection.